These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 31899343)

  • 1. microRNA-181 serves as a dual-role regulator in the development of human cancers.
    Rezaei T; Amini M; Hashemi ZS; Mansoori B; Rezaei S; Karami H; Mosafer J; Mokhtarzadeh A; Baradaran B
    Free Radic Biol Med; 2020 May; 152():432-454. PubMed ID: 31899343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-425: A Pivotal Regulator Participating in Tumorigenesis of Human Cancers.
    Sameti P; Amini M; Oroojalian F; Baghay Esfandyari Y; Tohidast M; Rahmani SA; Azarbarzin S; Mokhtarzadeh A; Baradaran B
    Mol Biotechnol; 2024 Jul; 66(7):1537-1551. PubMed ID: 37332071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of the microRNA-302/367 cluster in cancer therapy.
    Liu J; Wang Y; Ji P; Jin X
    Cancer Sci; 2020 Apr; 111(4):1065-1075. PubMed ID: 31957939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of pivotal microRNAs involved in the development and progression of salivary adenoid cystic carcinoma.
    Zhu QH; Meng Y; Tang YT; Hou CX; Sun NN; Han W; Wang CX; Ye J
    J Oral Pathol Med; 2022 Feb; 51(2):160-171. PubMed ID: 34797582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A step-by-step microRNA guide to cancer development and metastasis.
    Markopoulos GS; Roupakia E; Tokamani M; Chavdoula E; Hatziapostolou M; Polytarchou C; Marcu KB; Papavassiliou AG; Sandaltzopoulos R; Kolettas E
    Cell Oncol (Dordr); 2017 Aug; 40(4):303-339. PubMed ID: 28748501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dual role of microRNA (miR)-20b in cancers: Friend or foe?
    İlhan A; Golestani S; Shafagh SG; Asadi F; Daneshdoust D; Al-Naqeeb BZT; Nemati MM; Khalatbari F; Yaseri AF
    Cell Commun Signal; 2023 Jan; 21(1):26. PubMed ID: 36717861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The crosstalk between miRNAs and signaling pathways in human cancers: Potential therapeutic implications.
    Shekhar R; Kumari S; Vergish S; Tripathi P
    Int Rev Cell Mol Biol; 2024; 386():133-165. PubMed ID: 38782498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-141-3p is upregulated in esophageal squamous cell carcinoma and targets pleckstrin homology domain leucine-rich repeat protein phosphatase-2, a negative regulator of the PI3K/AKT pathway.
    Ishibashi O; Akagi I; Ogawa Y; Inui T
    Biochem Biophys Res Commun; 2018 Jun; 501(2):507-513. PubMed ID: 29738771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The intricate role of miR-155 in carcinogenesis: potential implications for esophageal cancer research.
    Nariman-Saleh-Fam Z; Saadatian Z; Daraei A; Mansoori Y; Bastami M; Tavakkoli-Bazzaz J
    Biomark Med; 2019 Feb; 13(2):147-159. PubMed ID: 30672305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging role of non-coding RNAs in the regulation of PI3K/AKT pathway in the carcinogenesis process.
    Ghafouri-Fard S; Abak A; Tondro Anamag F; Shoorei H; Majidpoor J; Taheri M
    Biomed Pharmacother; 2021 May; 137():111279. PubMed ID: 33493969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs and the PTEN/PI3K/Akt pathway in gastric cancer (Review).
    Hu M; Zhu S; Xiong S; Xue X; Zhou X
    Oncol Rep; 2019 Mar; 41(3):1439-1454. PubMed ID: 30628706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNAs (lncRNAs) and microRNAs regulatory pathways in the tumorigenesis and pathogenesis of glioma.
    Wu Y; Qian Z
    Discov Med; 2019 Sep; 28(153):129-138. PubMed ID: 31926584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulated expression and functions of microRNA-330 in cancers: A potential therapeutic target.
    Jafarzadeh A; Paknahad MH; Nemati M; Jafarzadeh S; Mahjoubin-Tehran M; Rajabi A; Shojaie L; Mirzaei H
    Biomed Pharmacother; 2022 Feb; 146():112600. PubMed ID: 34968919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-224: as a potential target for miR-based therapy of cancer.
    Chen W; Fan XM; Mao L; Zhang JY; Li J; Wu JZ; Tang JH
    Tumour Biol; 2015 Sep; 36(9):6645-52. PubMed ID: 26254100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
    Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
    Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-217: a therapeutic and diagnostic tumor marker.
    Hamidi AA; Zangoue M; Kashani D; Zangouei AS; Rahimi HR; Abbaszadegan MR; Moghbeli M
    Expert Rev Mol Diagn; 2022 Jan; 22(1):61-76. PubMed ID: 34883033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Roles of miR-25 and its Targeted Genes in Development of Human Cancer.
    Caiazza C; Mallardo M
    Microrna; 2016; 5(2):113-119. PubMed ID: 27594089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs: novel regulators in the hallmarks of human cancer.
    Ruan K; Fang X; Ouyang G
    Cancer Lett; 2009 Nov; 285(2):116-26. PubMed ID: 19464788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A MicroRNA Screen Identifies the Wnt Signaling Pathway as a Regulator of the Interferon Response during Flavivirus Infection.
    Smith JL; Jeng S; McWeeney SK; Hirsch AJ
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
    Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
    J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.